| H1 2026 Trading Update | 23-Jul-2026 | 07:00 | RNS |
| Change of Auditor | 13-Jul-2026 | 07:00 | RNS |
| Holding(s) in Company | 09-Jun-2026 | 07:00 | RNS |
| Grant of awards under Long Term Incentive Plan | 29-May-2026 | 07:00 | RNS |
| Capital Markets Day | 20-May-2026 | 07:00 | RNS |
| Result of AGM | 13-May-2026 | 13:40 | RNS |
| Holding(s) in Company | 12-May-2026 | 09:45 | RNS |
| £6m Influenza HCT contract signed | 07-May-2026 | 07:00 | RNS |
| Director/PDMR Shareholding | 24-Apr-2026 | 18:14 | RNS |
| HCT contract signed with ILiAD Biotechnologies | 22-Apr-2026 | 07:00 | RNS |
| Annual Report & Notice of AGM | 17-Apr-2026 | 07:00 | RNS |
| Final Results 2025 | 15-Apr-2026 | 07:00 | RNS |
| Influenza HCT contract signed with Traws Pharma | 14-Apr-2026 | 07:00 | RNS |
| Notice of Results | 07-Apr-2026 | 07:00 | RNS |
| Holding(s) in Company | 26-Mar-2026 | 17:19 | RNS |
| Currency | UK Pounds |
| Share Price | 6.55p |
| Change Today | -0.050p |
| % Change | -0.76 % |
| 52 Week High | 10.15 |
| 52 Week Low | 4.59 |
| Volume | 1,083,062 |
| Shares Issued | 688.40m |
| Market Cap | £45.09m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Latest | Previous | |
|---|---|---|
| Final | Final | |
| Ex-Div | 15-May-25 | 18-Apr-24 |
| Paid | 11-Jun-25 | 20-May-24 |
| Amount | 0.20p | 0.20p |
| Time | Volume / Share Price |
| 16:35 | 126,422 @ 6.55p |
| 16:35 | 124,112 @ 6.55p |
| 16:35 | 1,800 @ 6.55p |
| 16:35 | 510 @ 6.55p |
| 16:25 | 138,948 @ 6.51p |
You are here: research